This module is designed to help medical affairs professionals effectively evaluate scientific literature so they can identify and provide relevant and reliable information to health care professionals regarding the use of a particular drug.
This module takes an average of 4 hours to complete.
This eLearning module can be purchased individually or as part of the Medical Communications eLearning Program (eight modules).
- Study design and controls
- Measuring study results
- Describing the data
- Presenting the results
- Interpreting the results
- Establishing causality
- Determining importance and generalizability of results
Who should attend?
This program is designed for professionals involved in:
- Medical affairs
- Medical communications
- Medical information
- Medical writing
- Field-based medical affairs support (i.e., medical science liaison)
- Medical call center environment
- Regulatory affairs
- Clinical research
- Professional education, training, and development
- Document management/eSubmissions
Upon completion of this module, learners should be able to:
- Explain the purpose, key features and possible bias in a study abstract and introduction
- Evaluate whether subjects in a study were appropriately selected, and are representative of the subjects who will receive the drug
- Evaluate the internal validity of a clinical drug trial
- Identify efficacy, safety, and effectiveness outcomes of a study
- Identify missing data and evaluate Intention to Treat (ITT) analysis
- Explain how data is described in a study
- Explain how tables and graphs can be used effectively, but can also sometimes misrepresent data
- Evaluate whether study results are objectively interpreted
- Explain causal and non-causal relationships, and criteria for causality
- Explain the role that population size, cause, strength, randomization, and generalizability play in determining the importance of a study